Skip to main content
. 2022 Mar 15;14(3):643. doi: 10.3390/pharmaceutics14030643

Table 1.

Summary of formulations administered to rats and number of rats enrolled into each stage and group. R–reference formulation, T1–T3—innovative formulations.

Stage Group Formulations Number of Rats
1 A R/T1 4
B R/T1 4
2 C R/T2 6
D R/T2 4
3 E R/T3 3
F R/T3 3
4 IIV R/R 6